Microbial testing is not one certificate issued once for an entire hair care line. It is a risk-based control system linking formula design, purified water, raw materials, manufacturing hygiene, packaging, preservation and finished-product release.
For private label brands, the practical question is not simply “Did the sample pass?” It is whether the correct tests, acceptance criteria, sampling points and responsibilities have been defined for the product, market and manufacturing stage.
Many shampoos, conditioners, masks, scalp serums, leave-in sprays and styling creams contain substantial water and ingredients that can support microbial survival if preservation and manufacturing controls are inadequate. A product may also be exposed repeatedly after opening through wet hands, bathroom humidity, a jar opening, a contaminated pump or backflow around a closure.
Microbial contamination can change odor, color, viscosity, pH or appearance. More importantly, harmful or objectionable microorganisms may create a consumer safety risk even when the product still looks normal. The U.S. Food and Drug Administration explains that cosmetics do not have to be sterile, but they must not contain harmful microorganisms and should have low aerobic microbial counts. FDA also identifies contaminated raw materials, water, poor manufacturing conditions, ineffective preservation, unsuitable packaging and consumer use as potential contamination routes. See FDA’s official overview of microbiological safety and cosmetics.
The appropriate control plan depends on product risk. A water-rich botanical scalp mist is not evaluated in the same way as a nearly anhydrous hair oil, and a rinse-off shampoo is not automatically low risk because it is washed away. Target users, application area, formula pH, water activity, alcohol content, packaging and foreseeable use all matter.
A typical water-based private label hair care product may require a combination of:
These tests are related but not interchangeable. A low count on one freshly made batch does not prove that the formula can resist contamination during consumer use. A passed challenge test does not prove that every production batch was manufactured without contamination.
| Activity | Core question | Typical stage | What it does not prove |
|---|---|---|---|
| Microbial limits | What viable microbial population is detected in this sample, and are specified organisms absent under the method? | Pilot, stability checkpoints and/or batch release according to the quality plan | Long-term robustness of the preservative system |
| Preservation challenge test | Can the finished formula reduce or control defined organisms after intentional inoculation? | Formula qualification and relevant reformulation or change assessment | Hygiene or conformance of every commercial batch |
| Environmental and water monitoring | Are utilities and controlled production areas operating within established conditions? | Routine manufacturing control | Finished-product acceptability by itself |
| Stability and package compatibility | Do formula, preservative availability and package protection remain suitable under anticipated storage and use? | Development, accelerated/real-time stability and change control | A batch-specific microbial result unless microbiology is included |
Finished-product microbiology generally combines quantitative enumeration with qualitative screening for specified microorganisms. Depending on the agreed standard and market, the report may address total aerobic mesophilic microorganisms, yeast and mould, and the absence of named organisms in a defined sample quantity.
FDA’s Bacteriological Analytical Manual Chapter 23 describes methods for microbiological analysis of cosmetics, including direct colony counts and enrichment approaches. Internationally, ISO 17516:2014 supports assessment of the microbiological quality of cosmetic products. A laboratory may use a current ISO method, FDA BAM method, validated internal method or another accepted method appropriate to the market and product.
A useful report should identify the sample, batch or lot, method, sample quantity, units, results, specification, test dates and conclusion. “Pass” without the underlying method and result is weak documentation. The brand should also confirm whether the method was shown to recover microorganisms from that specific formula. Preservatives, surfactants, high alcohol or extreme pH can inhibit the test system and create an artificially low result unless the method uses suitable dilution, neutralization and recovery controls.
Do not copy numeric limits from a competitor’s certificate. Acceptance criteria should be selected by qualified Quality and Regulatory personnel from the current applicable standard, product risk, user population and destination-market requirements. Standards can be revised, and different product categories may require different criteria.
A preservation efficacy test intentionally introduces defined microorganisms into the finished product and follows their behavior over specified time points. The goal is to evaluate the product’s overall antimicrobial protection, not merely to show that the initial sample had a low count.
ISO 11930:2019 specifies a procedure for interpreting preservation efficacy test data and microbiological risk assessment when evaluating a cosmetic product’s antimicrobial protection. Its framework includes a preservation efficacy test and an evaluation route for products that are not considered low risk. The applicable edition, amendments, protocol and criteria must be confirmed with the laboratory and destination-market reviewer.
A challenge test is typically considered during formula qualification, especially for water-based emulsions, shampoos, conditioners, masks, gels and sprays. Retesting or documented reassessment may be needed when a change could affect preservation, including:
The manufacturer and brand should define change-control triggers before launch. A generic supplier statement that an ingredient “is preserved” is not a substitute for evaluating the final formula.
Water activity—not water percentage alone—affects whether microorganisms can grow.
Extreme pH or sufficient alcohol may lower risk, but the complete formula needs documented assessment.
Natural powders, extracts and some aqueous ingredients can introduce variability or preservation demand.
Water system, cleaning, hold time, temperature, transfer and filling affect contamination opportunity.
Jars permit direct contact; pumps and tubes may reduce exposure but still require compatibility evaluation.
Wet bathroom use, damaged skin, young children or other sensitive-use scenarios can raise concern.
Some products may present low microbiological risk because of low water activity, high alcohol, extreme pH, manufacturing conditions or protective packaging. ISO 29621:2017 provides guidelines for risk assessment and identification of microbiologically low-risk cosmetic products.
An anhydrous hair oil or dry styling powder may be a candidate for risk assessment, but “water-free” is not an automatic waiver from quality controls. Water can enter during manufacturing or use, raw materials can carry microorganisms, and the package can influence exposure. Similarly, a concentrate diluted by the consumer needs assessment of foreseeable dilution and use.
Low-risk status should be a documented technical conclusion made by qualified personnel. The record should explain formula characteristics, raw materials, process, packaging, intended use and supporting data. It should not be based only on product category or marketing language such as “natural,” “clean” or “preservative-free.”
A finished-product result is a snapshot from a submitted sample. Reliable production needs controls upstream:
| Control point | What to define | Typical evidence for brand review | Common warning sign |
|---|---|---|---|
| Process water | Water specification, sampling points, test frequency and action process | Current specification and representative monitoring records | No defined sampling point near use |
| Raw materials | Risk classification, supplier qualification and incoming controls | COA requirements, material specification and risk-based verification | Every supplier COA accepted without qualification |
| Equipment and cleaning | Cleaning method, inspection, verification and maximum clean/dirty hold time | Approved procedures and completed batch/cleaning records | Visible cleanliness treated as the only verification |
| Bulk manufacture | Temperature, pH, mixing, preservative addition and bulk hold limits | Master formula, batch record and in-process results | Long, undefined waiting time before filling |
| Filling and packaging | Component cleanliness, line clearance, exposure time and closure controls | Packaging specification and production record | Uncontrolled handling of product-contact parts |
| Finished-batch release | Sampling plan, specification, authorized reviewer and deviation procedure | COA/test report, release approval and retained-sample record | Shipment before required results and disposition |
FDA’s cosmetic GMP inspection checklist states that raw materials, in-process samples and finished products should be tested or examined for conformance with specifications, including microbial contamination where relevant. See the official FDA cosmetics GMP checklist.
A natural-origin formula is not inherently more or less microbiologically safe. Botanical waters, extracts and powders can increase formulation complexity, while organic acids, multifunctional ingredients and other preservation approaches depend strongly on pH, solubility, partitioning and the finished system.
A “preservative-free” positioning can also be misleading if the formula relies on multifunctional ingredients with antimicrobial effects. More importantly, the marketing phrase does not remove the need to establish safety and quality. Formulators should design from product risk and evidence, then have Regulatory review the final wording.
Reducing or removing a conventional preservative after a sample passes is a formula change that can invalidate earlier challenge-test and stability conclusions. The commercial formula tested should match the formula authorized for production.
FDA does not approve ordinary cosmetic formulas or issue a universal microbiology certificate before marketing. The responsible company must ensure the cosmetic is safe and not adulterated. The appropriate evidence and specifications depend on the product. FDA provides cosmetic microbiology methods and considers contamination sources in manufacturing and use; private label status does not transfer every legal and quality responsibility away from the brand.
Under Regulation (EC) No 1223/2009, the Cosmetic Product Safety Report includes microbiological specifications for substances or mixtures and the cosmetic product, with particular attention to certain sensitive areas and populations, as well as results of the preservation challenge test. The consolidated regulation effective 1 September 2025 is available on EUR-Lex. The EU Responsible Person and qualified safety assessor need the actual formula, packaging and supporting data; a generic factory certificate alone is not a complete Product Information File.
Market-specific review is essential. Other jurisdictions can apply different standards, notification systems, documentation expectations or test conventions. Confirm destination markets before approving the protocol and artwork.
Confirm cosmetic status, target markets, users, format, package and foreseeable use.
Review water activity, pH, materials, process, preservative system and exposure.
Define methods, specifications, laboratory, samples, timing and acceptance criteria.
Use the approved formula, process and intended packaging wherever the protocol requires them.
Check sample identity, method, results, criteria, deviations and authorized conclusion.
Release batches under specification and reassess relevant formula, process or package changes.
Review KINODIN’s hair care product portfolio, learn about OEM and private label development, and explore the company’s manufacturing background. For practical project questions, visit the FAQ or send the product brief through the contact page.
Send your target market, product type, formula or ingredient direction, packaging format, user group, estimated quantity and launch timing. KINODIN can review the development brief and identify microbiology, stability and documentation questions for the next project stage.
Send Your Product BriefWritten by KINODIN Content Team
Technical review by KINODIN R&D / Quality Team
Last reviewed: September 2026
Copyright © 2026 Foshan Younik Cosmetics Co., Limited. All Rights Reserved.